TG-rich lipoproteins: stars or second advantage in the field of residual CV risk?
Alberto Zambon
September 5, 2024 | EAS-LatAm webinar series, Webinars on-demand
Potential atherogenicity of trygliceride-rich lipoproteins
Laura Schreier
September 5, 2024 | EAS-LatAm webinar series, Webinars on-demand
Barriers to achieving LDL cholesterol goals in LATAM
Dora Ines Molina de Salazar, Isabel Cristina Cárdenas Moreno
June 26, 2024 | EAS-LatAm webinar series, Webinars on-demand
What are the therapeutic objectives of LDL, Non-HDL cholesterol, lipoprotein (a), and apolipoprotein B according to cardiovascular risk?
Dora Ines Molina de Salazar
June 26, 2024 | EAS-LatAm webinar series, Webinars on-demand
Dyslipidemia and cardiovascular risk in LATAM
Isabel Cristina Cárdenas Moreno
June 26, 2024 | EAS-LatAm webinar series, Webinars on-demand
Contribution of genetics
Pradeep Natarajan
May 29, 2024 | 92nd EAS Congress 2024, Plenary 03
Contribution of imaging
Giovanna Liuzzo
May 29, 2024 | 92nd EAS Congress 2024, Plenary 03
Contribution of metabolomics and inflammation
Samia Mora
May 29, 2024 | 92nd EAS Congress 2024, Plenary 03
Multi-omics in CV-medicine
Erik Stroes
May 29, 2024 | 92nd EAS Congress 2024, Plenary 03
The role of ANGPTL8 in the regulation of triglyceride metabolism
Robert Konrad
May 29, 2024 | New insights in the regulation of Lipid/Lipoproteins metabolism, 92nd EAS Congress 2024